Klivira
Request demo

Optimizing Lantus Prior Authorization for Dermatology Practices

Navigating **Lantus prior authorization for dermatology** patients requires an integrated approach that accounts for both the patient's primary dermatological care and any co-managed conditions.

While dermatological prior authorizations primarily focus on biologics, specialty topicals, and procedures like Mohs surgery, many patients present with comorbid conditions requiring medications such as Lantus. Revenue cycle and prior authorization teams in dermatology must manage a diverse PA landscape, ensuring efficient approval for all necessary treatments. Klivira helps consolidate these complex workflows.

The Intersection of Diabetes Management and Dermatological Care

Dermatology practices frequently treat patients with complex health profiles, including those managing diabetes with medications like Lantus. While Lantus (insulin glargine) is not a dermatological drug, its prior authorization process can become an incidental part of a dermatology practice's broader PA management, particularly when patients have multiple specialists or a comprehensive patient record is required for other treatments. Efficient systems must support these co-managed medication authorizations.

Prior Authorization Landscape in Dermatology

The core of dermatology prior authorization centers on high-cost specialty drugs and complex procedures. This includes biologics for conditions such as psoriasis (e.g., TNF inhibitors, IL-17/IL-23 inhibitors) and atopic dermatitis (e.g., dupilumab), as well as medications for hidradenitis suppurativa and advanced skin cancers. Mohs micrographic surgery also represents a significant volume of PA requests, with payer policies varying on indications and site specificity.

Key Documentation Considerations for Dermatology-Focused Prior Authorizations

  • Diagnosis criteria and severity scores (e.g., PASI/BSA for psoriasis, EASI/SCORAD for atopic dermatitis).
  • Trial and failure documentation for prior topical, phototherapy, or conventional systemic therapies.
  • Pre-biologic screening results (e.g., TB, hepatitis) and compliance with step therapy protocols.
  • Adherence to Appropriate Use Criteria (AUC) for procedures like Mohs surgery, specifying site and tumor type.
  • Age-appropriate indications and specific contraindications as per AAD Clinical Guidelines.

Navigating Co-Managed Medication Authorizations

For dermatology patients on medications like Lantus, prescribed by an endocrinologist or primary care provider, the prior authorization process often necessitates access to a comprehensive patient history. Klivira's EMR integration capabilities facilitate the aggregation of relevant clinical data, ensuring that all necessary information, regardless of prescribing specialty, is available to support PA submissions for both dermatological treatments and co-managed medications.

Common Prior Authorization Denial Reasons in Dermatology

  • Failure to document compliance with payer-mandated step therapy protocols for biologics.
  • Inadequate documentation of disease severity (e.g., missing PASI, EASI, or BSA scores).
  • Mohs AUC mismatch where the site or tumor type does not meet payer-specific indications.
  • Lack of documented pre-biologic screenings (e.g., TB, hepatitis) or other required lab results.
  • Biosimilar substitution requirements for TNF inhibitors not addressed in the submission.

Klivira's Role in Streamlining Dermatology Prior Authorization Workflows

Klivira's platform is engineered to address the complexities of dermatology PA. This includes AAD-guideline-aware step-therapy logic for biologics, AUC validation for Mohs surgery, and management of periodic re-authorization cycles typical for chronic dermatological conditions. By automating data extraction and submission, Klivira reduces manual effort and accelerates approval times, even for patients with diverse medication needs like Lantus.

Frequently asked questions

How does Klivira handle prior authorizations for biologics in dermatology?

Klivira's platform incorporates AAD-guideline-aware step-therapy logic, automates the collection of necessary clinical documentation like severity scores and prior treatment trials, and manages the periodic re-authorization workflow for chronic biologic treatments common in dermatology.

What are common reasons for prior authorization denials in dermatology?

Frequent denial reasons include insufficient documentation of step therapy compliance, Mohs AUC mismatches, inadequate disease severity scores (e.g., PASI, EASI, BSA), and missing pre-biologic screenings for medications like TNF inhibitors or IL-17/23 inhibitors.

Can Klivira integrate with our EMR to pull patient data for dermatology PAs?

Yes, Klivira offers robust EMR integration capabilities, including SMART on FHIR, to seamlessly pull patient demographics, clinical notes, lab results, and medication histories. This ensures that all necessary data for dermatology-specific PAs, or for co-managed medications like Lantus, is readily accessible for submission.

How does Klivira support the re-authorization process for chronic dermatological conditions?

Klivira automates the tracking of re-authorization cycles for chronic biologic treatments, proactively alerting teams when re-authorization is due. It streamlines the process by pre-populating forms with updated patient data, reducing the administrative burden and ensuring continuity of care.

Does Klivira assist with prior authorizations for medications like Lantus prescribed to dermatology patients?

While Lantus is not a dermatological drug, Klivira's platform streamlines the overall prior authorization process for a practice. By integrating with your EMR, it facilitates the aggregation of all patient health information, making it easier to manage PA requests for any medication a dermatology patient may be on, including those for comorbid conditions.

Related coverage

Other lantus prior authorization by payer

Other lantus prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo